Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-12-14

FDA Approved: RAXIBACUMAB — Original Application (Emergent Manufacturing Operations Baltimore LLC)

View source ↗

Summary

FDA approved raxibacumab under an original biologics license application for treatment of inhalational anthrax when used with antibiotics. The approval was issu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raxibacumab (raxibacumab)

Snippet

ORIG AP for RAXIBACUMAB (RAXIBACUMAB)